MiniMed Group (MMED) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on MiniMed Group (MMED) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.22 of bullish evidence against -0.40 bearish.

MiniMed Group last closed at $20.16, +2.34% on the session.

Against the IVW growth benchmark the position is +1.42% over the forecast window.

The read is built from 13 underlying insights — 5 bullish and 8 bearish.

Agreement across those insights is 62%.

16 graded predictions for MMED so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks MiniMed Group in the 32nd percentile on return on equity, where 100 is best.

MiniMed Group is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $5.64B.

StockMap tracks MiniMed Group as the 28th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite MiniMed Group ranks 80th of 133 in the group, against a group median of -0.21.